Management Agreements in the Biotechnology Industry

112 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fee Letter Agreement dated November 12, 2020 by and among the Company, the Avista Funds and the Management Company
Management Agreements
Organogenesis Holdings Inc.
Biotechnology
2020
Modification No. 3, dated September 27, 2024, to the ATI-RRPV Project Award Agreement No. 001, dated June 13, 2024, between Vaxart Biosciences Inc. and Advanced Technology...
Management Agreements
Vaxart, Inc.
2024
ATI-RRPV Project Award Agreement No. 001, dated June 13, 2024, between Vaxart Biosciences Inc. and Advanced Technology International (RRPV Consortium Management Firm)
Management Agreements
Vaxart, Inc.
2024
ATI-RRPV Base Agreement, dated May 6, 2024, between Vaxart Biosciences Inc. and Advanced Technology International (RRPV Consortium Management Firm)
Management Agreements
Vaxart, Inc.
2024
Management Services Agreement, effective as of June 1, 2024
Management Agreements
Allarity Therapeutics, Inc.
2024
Board Designation Agreement, dated April 22, 2024, by and between Benitec Biopharma Inc. and Suvretta Capital Management, LLC
Management Agreements
Benitec Biopharma Inc.
2024
Restructuring Support Agreement, dated as of March 26, 2024, by and among the Company Parties and the certain funds managed by Highbridge Capital Management LLC
Management Agreements
Gamida Cell Ltd.
2024
Second Amended and Restated Limited Partnership Agreement for a Limited Partnership Called ProKidney LP, dated as of July 11, 2022, as amended as of November 14, 2023, by and...
Management Agreements
Social Capital Suvretta Holdings Corp. III
2024
Cooperation Agreement, dated as of December 20, 2023, by and among the Company, Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P
Management Agreements
BIOMARIN PHARMACEUTICAL INC
2023
Management Services Agreement, effective as of September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A
Management Agreements
bioAffinity Technologies, Inc.
2023
Second Amendment to Revenue Interest Financing Agreement, dated as of August 1, 2023, by and among the Registrant, Karyopharm Europe GmbH, HealthCare Royalty Partners III, L.P.,...
Management Agreements
Karyopharm Therapeutics Inc.
2023
Agreement For Construction Management Services Between AquaBounty Farms Ohio LLC and Gilbane Building Company
Management Agreements
AquaBounty Technologies, Inc.
2023
Management Services Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, and Blue Water Biotech, Inc
Management Agreements
Blue Water Vaccines Inc.
2023
Amendment to the Cooperation Agreement, dated March 21, 2023, by and among Achieve Life Sciences, Inc., Dialectic Capital Management, LP and the other parties set forth on the...
Management Agreements
ACHIEVE LIFE SCIENCES, INC.
Biotechnology
2023
Cooperation Agreement, dated February 21, 2023, by and among Heron Therapeutics, Inc., Rubric Capital Management LP, the persons and entities listed on Schedule A thereto, Velan...
Management Agreements
HERON THERAPEUTICS, INC.
Biotechnology
DE
2023
Agreement, dated as of December 15, 2022, by and among Diffusion Pharmaceuticals Inc, LifeSci Special Opportunities Master Fund Ltd., LifeSci Special Opportunities Partners L.P.,...
Management Agreements
Diffusion Pharmaceuticals Inc.
Biotechnology
DE
2022
Advisory Services and Monitoring Agreement dated as of November 4, 2022 by and between Morgenesis LLC and Metalmark Management II LLC
Management Agreements
Orgenesis Inc.
Biotechnology
DE
2022
Revenue Interest Financing Agreement, dated June 16, 2022, by and between the Company and entities managed by HealthCare Royalty Management, LLC
Management Agreements
RHYTHM PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Second Amended and Restated Limited Partnership Agreement for a Limited Partnership Called ProKidney LP, dated as of July 11, 2022, by and among Tolerantia, LLC, Control...
Management Agreements
Social Capital Suvretta Holdings Corp. III
Biotechnology
NY
2022
Consent to Assignments, Licensing and Common Ownership and Invention Management Agreement dated December 15, 2016 by and between the Registrant, CRISPR Therapeutics AG, The...
Management Agreements
Intellia Therapeutics, Inc.
Biotechnology
CA
2022
Agreement dated December 17, 2021 by and between Petra Acquisition, Inc. and Monashee Investment Management LLC
Management Agreements
Petra Acquisition Inc.
Biotechnology
NY
2021
Management Services Agreement by and between the Company and Alwaysraise LLC, dated March 18, 2021
Management Agreements
Immix Biopharma, Inc.
Biotechnology
CA
2021
Revenue Interest Financing Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and entities managed by HealthCare Royalty Management, LLC
Management Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2021
Fourth Amendment to Second Amended and Restated Management Services Agreement, dated June 1, 2021, by and between the Company and Broadband Capital Partners LLC
Management Agreements
Immunome Inc.
Biotechnology
NY
2021
Second Amended and Restated Management Services Agreement, dated October 9, 2018, by and between Paragon Biosciences, LLC and Castle Creek Pharmaceuticals, LLC
Management Agreements
Castle Creek Biosciences, Inc.
Biotechnology
IL
2021
Consent to Assignments, Licensing and Common Ownership and Invention Management Agreement for a Programmable DNA Restriction Enzyme for Genome Editing, dated December 15, 2016, by...
Management Agreements
Caribou Biosciences, Inc.
Biotechnology
CA
2021
Cooperation Agreement, dated as of April 16, 2021, by and among uniQure N.V., ForUniqure B.V., Forbion 1 Management B.V., Forbion International Management B.V., and Forbion...
Management Agreements
uniQure N.V.
Biotechnology
2021
Amendment dated February 23, 2021 to the Expense Advancement Agreement, dated December 1, 2017 and amended on June 29, 2020, October 26, 2020 and November 30, 2020, by and between...
Management Agreements
Leisure Acquisition Corp.
Biotechnology
NY
2021
Management Services Agreement, effective as of October 1, 2014, by and between the Registrant and Araxes Pharma LLC
Management Agreements
Kura Oncology, Inc.
Biotechnology
CA
2021
Agreement, by and among ZIOPHARM Oncology, Inc., WaterMill Asset Management Corp. Robert W. Postma, Jamie Vieser, and Holger Weis, dated February 4, 2021
Management Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2021
Second Omnibus Amendment and Agreement dated January 12, 2021 by and between NTN Buzztime, Inc., eGames.com Holdings LLC and Fertilemind Management, LLC
Management Agreements
NTN BUZZTIME INC
Biotechnology
2021
Form of Contribution Agreement by and between Cullinan Oncology, LLC and Cullinan Management, Inc
Management Agreements
Cullinan Oncology, LLC
Biotechnology
DE
2021
Cooperation Agreement, dated December 10, 2020, by and among Alkermes plc, Elliott Investment Management L.P., Elliott Associates, L.P., Elliott Advisors (UK) Limited and Elliott...
Management Agreements
Alkermes plc.
Biotechnology
NY
2020
Management Services Agreement, by and between Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability partnership, and Avero Laboratory Holdings, LLC, a...
Management Agreements
PROGENITY, INC.
Biotechnology
TX
2020
Amendment dated November 30, 2020 to the Expense Advancement Agreement, dated December 1, 2017 and amended on June 29, 2020 and October 26, 2020, by and between the Company and...
Management Agreements
Leisure Acquisition Corp.
Biotechnology
NY
2020
Omnibus Amendment and Agreement dated November 19, 2020 by and between NTN Buzztime, Inc., eGames.com Holdings LLC and Fertilemind Management, LLC
Management Agreements
NTN BUZZTIME INC
Biotechnology
2020
Amendment dated August 7, 2020 to the Administrative Services Agreement between the Company and Hydra Management, LLC
Management Agreements
Leisure Acquisition Corp.
Biotechnology
2020
Amendment dated October 26, 2020 to the Expense Advancement Agreement, dated December 1, 2017 and amended on June 29, 2020, by and between the Company and Hydra Management, LLC,...
Management Agreements
Leisure Acquisition Corp.
Biotechnology
NY
2020
Letter Agreement, dated as of May 31, 2017, by and between HighCape Partners Management, L.P. and the Registrant
Management Agreements
AZIYO BIOLOGICS, INC.
Biotechnology
2020
Form of Subscription Agreement to be executed by certain Management Creditors
Management Agreements
GeoVax Labs, Inc.
Biotechnology
2020